|
Volumn 19, Issue 4, 2011, Pages 1541-1549
|
New imidazolidinedione derivatives as antimalarial agents
|
Author keywords
Antimalarials; Imidazolidinedione; Metabolic stability; Preparation
|
Indexed keywords
[6 [N' (3,4 DICHLOROPHENYL) N'' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL)GUANIDINO]HEXYL]CARBAMIC ACID TERT BUTYL ESTER;
ANTIMALARIAL AGENT;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
IMIDAZOLIDINE DERIVATIVE;
IMIDAZOLIDINEDIONE DERIVATIVE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' (2 ADAMANTYL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' (2 PYRROLIDIN 1 YLETHYL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' (4 PYRROLIDIN 1 YLBUTYL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' ALLYLOXYGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' BENZYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' BENZYLOXYGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' ETHOXYGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' ETHYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' ISOPROPYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' METHOXYGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' METHYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' PHENYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' TERT BUTOXYGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'' TERT BUTYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL) N'',N HEXYLGUANIDINE;
N (3,4 DICHLOROPHENYL) N' (2 DIETHYLAMINOETHYL) N'' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (2 DIMETHYLAMINOETHYL) N'' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (2,2 DIMETHYLPROPYL) N'' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL)GUANIDINE;
N (3,4 DICHLOROPHENYL) N' (3 DIMETHYLAMINOPROPYL) N'' (1 ISOPROPYL 4,5 DIOXO 4,5 DIHYDRO 1H IMIDAZOL 2 YL)GUANIDINE;
PRIMAQUINE;
TAFENOQUINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIMALARIAL ACTIVITY;
ARTICLE;
BENZYLATION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG STABILITY;
DRUG SYNTHESIS;
MALARIA;
MOUSE;
NONHUMAN;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
RHESUS MONKEY;
SPOROZOITE;
ANIMALS;
ANTIMALARIALS;
HUMANS;
IMIDAZOLIDINES;
MACACA MULATTA;
MICE;
MOLECULAR STRUCTURE;
PLASMODIUM BERGHEI;
PLASMODIUM CYNOMOLGI;
PLASMODIUM FALCIPARUM;
STRUCTURE-ACTIVITY RELATIONSHIP;
MACACA MULATTA;
MUS;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
|
EID: 79951553515
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.12.028 Document Type: Article |
Times cited : (17)
|
References (16)
|